By Sarah Mirando  |  August 10, 2012

Category: Pharmaceuticals

{loadposition yaz_yasmin_lawsuit} 
Follow us on Twitter and Facebook for the latest Yasmin, Yaz Class Action Lawsuit News!
 

Yaz Blood Clot Led to Leg Amputation, Lawsuit Says

By Kimberly Mirando

 

Yaz blood clot injuryA young woman from Wisconsin has filed a lawsuit against the makers of Yaz alleging the birth control pill caused her to suffer serious side effects, including a life-threatening blood clot called deep vein thrombosis. Her Yaz injuries were so severe that her right leg had to be amputated to save her life. Her Yaz lawsuit accuses Bayer and other Defendants of hiding the substantial risk of developing a severe blood clot from the public, which directly contributed to her injuries. Her case joins nearly 10,000 Yaz, Yasmin and Beyaz lawsuits pending in multidistrict litigation against Bayer alleging the oral contraceptives caused severe side effects, including blood clots, deep vein thrombosis, pulmonary embolism, heart attack, stroke, and more.

 
The young woman alleges in the Yaz blood clot lawsuit, filed May 24, 2012 in the U.S. District Court, Southern District of Illinois, that she was diagnosed with deep vein thrombosis — a blood clot in her leg — in September 2011, resulting in the amputation of her leg. According to her Yaz lawsuit, Bayer had been warned at least three times by the FDA in 2003, 2008 and 2009 to stop misleading the public through deceptive ads that overstated the efficacy of Yaz and minimized the serious risks associated with the drug. Bayer ultimately agreed to spend $20 million on a corrective advertising campaign, but many Yaz lawsuit Plaintiffs claim the new commercials still downplayed the seriousness of developing a Yaz blood clot. The unnamed Wisconsin woman alleges in her Yaz lawsuit that had Bayer properly disclosed the risks associated with Yaz, she would not have used it and would not have suffered the severe and permanent injuries she sustained.
 
Yaz was approved by the FDA in 2006, five years after its predecessor, Yasmin, was approved for use in 2001. A third version of the contraceptive, Beyaz, was approved in 2010. Yasmin, Yaz and Beyaz are different from older forms of birth control because they contain drospirenone, a synthetic progestin that can raise the body’s level of potassium. High potassium can disrupt normal heart rhythms, potentially leading to slow blood flow to the heart, causing blood clots to form. During the brief time Yasmin, Yaz and Beyaz have been on the market, the FDA has received hundreds of reports of blood clot injuries and even death associated with these drugs. Among these Yasmin/Yaz/Beyaz side effects reported are pulmonary embolism, deep vein thrombosis, heart attack, heart arrhythmia, stroke and wrongful death.
 
The FDA announced in April 2012 that it is requiring Bayer and other manufacturers of drospirenone birth control pills to update the labels for these drugs to include warnings about the higher risk of blood clots associated with them. The new warning labels will be applied to Yaz, Yasmin, Beyaz, Ocella, Gianvi, Loryna, Syeda, Zarah and Safyral. This is too little too late for many blood clot victims, however, who have already suffered serious injuries from taking a drug they were not properly warned about.
 
Nearly 10,000 Yasmin, Yaz and Beyaz lawsuits have been filed in U.S. federal courts seeking compensation for blood clot injuries. All lawsuits concerning these drugs have been consolidated into a multidistrict litigation (MDL) known as In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100) in the Southern District of Illinois. Lawsuits in the Yasmin/Yaz/Beyaz MDL are quickly settling. So far, nearly 1,500 Yaz/Yasmin/Beyaz lawsuit settlements have been reached, paying out millions of dollars in compensation.
 
If you suffered a severe blood clot injury from taking Yasmin, Yaz, Beyaz, Ocella or another drospirenone birth control pill, you deserve to be compensated, too. Submit your information for a free consultation from a Yaz law firm that specializes in obtaining compensation for blood clot victims. During this no-obligation consultation, you’ll learn your legal options and rights, and whether you’re a good fit to file a Yaz injury lawsuit, Yaz class action lawsuit or to join the Yasmin and Yaz MDL.
 
Don’t wait — lawsuits in the Yasmin and Yaz MDL are settling quickly, and there is a statute of limitations for filing claims. Visit the Yaz/Yasmin, Beyaz & Ocella Birth Control Pill Class Action Lawsuit Settlement & Investigation for more information.
 

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

Updated August 10th, 2012

 

{loadposition content_postads}

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2012 Top Class Actions® LLC
Various Trademarks held by their respective owners.

One thought on Yaz Blood Clot Led to Leg Amputation, Lawsuit Says

  1. Pingback: Plinko game

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.